CKS1B and breast carcinoma: It has been reported in breast cancer, lung cancer, ovarian carcinoma, and multiple myeloma [35–38] that the overexpressed CKS1B resulted in the tumor progression by promoting the degradation of p27Kip1 and patients with high CKS1B expression presented poor prognosis [39, 40].